Davis Polk – Manchester United’s Initial Public Offering

Davis Polk advised Jefferies & Company, Inc., Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Deutsche Bank Securities Inc. as joint book-running managers in connection with the $233 million initial public offering of 16,666,667 Class A ordinary shares of Manchester United plc. Of these shares, Manchester United offered 8,333,334 shares and the selling shareholder offered 8,333,333 shares. The Class A ordinary shares are listed on the New York Stock Exchange under the symbol “MANU.”

More >>

Tags:  Davis Polk & Wardwell | New York

Shearman & Sterling Advises on Public Offering of Cheniere Energy

Shearman & Sterling represented Credit Suisse Securities (USA) LLC, Morgan Stanley & Co. LLC and RBC Capital Markets, LLC as underwriters of a public offering of 28,000,000 shares of Cheniere Energy, Inc. common stock. The Underwriters have the option to purchase up to 4,200,000 additional shares of common stock at any time within 30 days of the offering.

More >>

Tags:  Shearman & Sterling LLP | New York

Simpson Thacher Represents Teleflex Incorporated in its Acquisition of Assets of LMA International N.V.

The Firm is representing Teleflex Incorporated (NYSE: TFX) in connection with its announced acquisition of substantially all of the assets of LMA International N.V. (“LMA”) for SGD 343.5 million in cash, which at current exchange rates translates into approximately $276 million. LMA is a public company listed on the Mainboard of the Singapore Exchange that provides laryngeal masks and other products used extensively in anesthesia and emergency care. The transaction, which is subject to customary closing conditions, is expected to close later this year.

More >>

Tags:  Simpson Thacher & Bartlett LLP | New York

Willkie Advises Special Committee on Buyout of Taro Pharmaceutical Industries

On August 12, it was announced that Israel-based Taro Pharmaceutical Industries Ltd. has accepted an improved buyout offer from India-based Sun Pharmaceutical Industries Ltd., Taro’s majority shareholder. The merger agreement was approved by Taro’s Board of Directors, based upon the recommendations and approvals of its Special Committee, represented by Willkie, and its Audit Committee.

More >>

Tags:  Willkie Farr & Gallagher LLP | New York

Simpson Thacher Represents Underwriters in $2.8 Billion Notes Offering by Altria Group, Inc.

The Firm recently represented the underwriters, led by Citigroup, Deutsche Bank and J.P. Morgan, in connection with a public offering by Altria Group, Inc. of $1.9 billion aggregate principal amount of its 2.850% Notes due 2022 and $900 million aggregate principal amount of its 4.250% Notes due 2042. The offering closed on August 9, 2012.

More >>

Tags:  Simpson Thacher & Bartlett LLP | New York

Locke Lord’s Antitrust Capabilities Boosted by Addition of New Litigation Partner Paul Kaplan in Firm’s New York Office

Antitrust Litigation Partner Paul Kaplan has joined Locke Lord’s New York office as part of the Firm’s Litigation Department and Antitrust Practice Group. He brings more than 25 years of experience in handling litigation and counseling for major corporations as well as for domestic and international financial institutions. His significant background and experience in antitrust matters across numerous industries will strengthen the national platform of the Firm’s Antitrust Practice.

More >>

Tags:  Locke Lord LLP | New York

Milbank Represents Underwriters in $300 million Registered Offering of Senior Notes by BRE Properties, Inc.

International law firm Milbank, Tweed, Hadley & McCloy LLP, led by Global Securities partner Rob Williams, represented J.P. Morgan, RBS, Wells Fargo Securities and a syndicate of ten other underwriters in connection with the registered public offering by BRE Properties, Inc. (“BRE”) of $300 million 3.375% Senior Notes due 2023.

More >>

Tags:  Milbank LLP | New York